《大行》里昂:信義光能(00968.HK)上半年業績稍勝預期 目標價4元
里昂研究報告指,在上半年海外產能需求相對強勁及盈利能力良好的帶動下,信義光能(00968.HK)上半年業績較去年下半年有所改善,公司預期淨利潤將達6.15億至7.96億元人民幣,略好過該行原先預期的5億至6億元人民幣;該行料上半年太陽能玻璃的每單位淨利潤超過每平方米0.5元人民幣。
搶裝潮過後需求轉弱,太陽能玻璃龍頭企業已開始對窯爐進行冷修並延遲產能擴張,日均熔煉量由6月的10萬噸降至7月中的9.2萬噸。該行仍然相信於潛在的供給端改革下,太陽能玻璃龍頭企業將處於更有利地位;現予信義光能目標價4元及「跑贏大市」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.